Delivery Order SPE2DB22D3301-SPE2DB24FY6NN

Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $4.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TENIVAC SYRINGE 0.5ML medical supplies to the Defense Logistics Agency (DLA). The $8,702.96 firm fixed-price delivery order has a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award, valued at $1,135.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TENIVAC SYRINGE 0.5ML, a medical supply item, with a completion date of March 11, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, valued at up to $4,911.66, is for the delivery of TENIVAC SYRINGE 0.5ML, a medical product, to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the TENIVAC SYRINGE 0.5ML medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and a Ceiling Value of $1,085.45. The contract has an Ultimate Completion Date of July 24, 2024. This award is not designated as a Set-Aside contract. Amerisourcebergen Drug Corp's Corporate Office division is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,302.54 firm fixed-price delivery order is for TENIVAC SYRINGE 0.5ML, a medical supply product. The contract has an ultimate completion date of July 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,380.83 firm fixed price delivery order is for the TENIVAC VIAL 0.5ML product, with a completion date of June 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the procurement of TENIVAC syringes, 0.5 mL, with a ceiling value of $1,128.04 and a completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $3,985.80 firm fixed-price delivery order is for the product "TENIVAC VIAL 0.5ML" with a completion date of May 23, 2024. The contract has no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TENIVAC SYRINGE 0.5ML. The contract has a firm fixed price of $4,171.55 and an ultimate completion date of August 1, 2024. The contract is not set aside for any socioeconomic program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a Firm Fixed Price Delivery Order contract worth $7,427.20 for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML. This contract has a completion date of July 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY6NN
    Delivery Order

This federal contract award, valued at $4,850.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TENIVAC SYRINGE 0.5ML medical supplies and has a completion date of May 13, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation to provide a wide range of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense and Veterans Affairs healthcare systems. This contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a subsidiary, Amerisourcebergen leverages its parent company's extensive supply chain network to efficiently fulfill these government contracts.

Generated 8/9/24, 9:15 AM